These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30909080)

  • 41. [Integrin α5 silencing inhibits proliferation, invasion and metastasis of human liver cancer Bel-7404 cells
    Guo Y; Xu G; Shan M; Yang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):893-898. PubMed ID: 32895194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
    Yan T; Ye XX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5139-5148. PubMed ID: 31298367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
    Yang G; Yang Y; Tang H; Yang K
    Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway.
    Lu Y; Lin J; Duan M; Rui Y; Zheng H; Zhu L; Zhu X; Wei J
    Anal Cell Pathol (Amst); 2021; 2021():5228713. PubMed ID: 34926131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrin α5/ITGA5 Promotes The Proliferation, Migration, Invasion And Progression Of Oral Squamous Carcinoma By Epithelial-Mesenchymal Transition.
    Deng Y; Wan Q; Yan W
    Cancer Manag Res; 2019; 11():9609-9620. PubMed ID: 32009816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in regulating the progression of oral squamous cell carcinoma.
    Sun Y; Yang X; Guan S; Ma T; Jiang Z; Gao M; Xu Y; Cong B
    Arch Oral Biol; 2023 Dec; 156():105810. PubMed ID: 37852106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.
    Peng X; Liu Y; Zhu S; Peng X; Li H; Jiao W; Lin P; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2921-2936. PubMed ID: 31620898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma.
    Liu J; Wang Y; Chen X; Chen X; Zhang M
    Diagn Pathol; 2024 Oct; 19(1):134. PubMed ID: 39375732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
    Sasabe E; Tomomura A; Yamamoto T
    J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
    Shan F; Shen S; Wang X; Chen G
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
    Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
    Long W; Gong X; Yang Y; Yang K
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro.
    Smolensky D; Rathore K; Bourn J; Cekanova M
    J Cell Biochem; 2017 Sep; 118(9):2615-2624. PubMed ID: 27649518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
    Sento S; Sasabe E; Yamamoto T
    PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway.
    Wei M; Wu Y; Liu H; Xie C
    Drug Des Devel Ther; 2020; 14():395-405. PubMed ID: 32099325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
    Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
    Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
    Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
    Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α signaling pathway.
    Wei J; Wu J; Xu W; Nie H; Zhou R; Wang R; Liu Y; Tang G; Wu J
    Cell Death Dis; 2018 May; 9(6):599. PubMed ID: 29789538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
    He W; Lai R; Lin Q; Huang Y; Wang L
    J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.